Lv4
590 积分 2025-03-13 加入
A phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
22天前
已完结
A Phase 3 Study Comparing the Activity of Momelotinib in Symptomatic and Anemic Myelofibrosis Patients Versus Danazol
1个月前
已完结
Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma
2个月前
已关闭
Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study
2个月前
已完结
Heterogeneity and treatment landscape of ovarian carcinoma
2个月前
已完结
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review
2个月前
已完结
Small-cell lung cancer
2个月前
已完结
Emerging Strategies for the Treatment of Small Cell Lung Cancer
2个月前
已完结
Small cell lung cancer
2个月前
已完结
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
